CorMedix Inc
CRMD14.350USD
+0.210+1.49%
Fechamento 08/28, 16:00（ET）Cotações atrasadas em 15 min
1.07BValor de mercado
62.33P/L TTM
Mais detalhes de CorMedix Inc Empresa
CorMedix Inc. is a biopharmaceutical company. The Company is focused on developing and commercializing therapeutic products for the prevention and treatment of life-threatening conditions and diseases. The Company is focused on commercializing its lead product DefenCath, which is an antimicrobial catheter lock solution approved to reduce the incidence of catheter-related bloodstream infections in adult patients with kidney failure receiving chronic hemodialysis through a central venous catheter. DefenCath is a formulation of taurolidine 13.5 mg/mL, and heparin 1000 USP Units/mL indicated to reduce the incidence of catheter-related bloodstream infections (CRBSI) in adult patients with kidney failure receiving chronic hemodialysis through a central venous catheter (CVC). In addition to DefenCath, the Company has sponsored a pre-clinical research collaboration for the use of taurolidine as a possible treatment for rare pediatric tumors.
Informações da empresa
Código da empresaCRMD
Nome da EmpresaCorMedix Inc
Data de listagemMar 25, 2010
CEOMr. Joseph Todisco
Número de funcionários64
Tipo de títulosOrdinary Share
Fim do ano fiscalMar 25
Endereço300 Connell Drive
CidadeBERKELEY HEIGHTS
Bolsa de valoresNASDAQ Global Market Consolidated
PaísUnited States of America
Código postal07922
Telefone19085179500
Sitehttps://cormedix.com/
Código da empresaCRMD
Data de listagemMar 25, 2010
CEOMr. Joseph Todisco
Executivos da empresa
Nome
Nome/Posição
Posição
Ações detidas
Variação
Mr. Joseph Todisco
Mr. Joseph Todisco
Chief Executive Officer, Director
Chief Executive Officer, Director
323.43K
-2.01%
Mr. Steven W. Lefkowitz
Mr. Steven W. Lefkowitz
Independent Director
Independent Director
127.65K
-3.77%
Ms. Janet M. Dillione
Ms. Janet M. Dillione
Independent Director
Independent Director
53.47K
-31.86%
Ms. Erin Mistry
Ms. Erin Mistry
Executive Vice President, Chief Commercial Officer
Executive Vice President, Chief Commercial Officer
29.12K
-54.14%
Mr. Robert Stewart
Mr. Robert Stewart
Independent Director
Independent Director
11.00K
-69.44%
Mr. Dan Ferry
Mr. Dan Ferry
IR Contact Officer
IR Contact Officer
--
--
Dr. Alan William Dunton, M.D.
Dr. Alan William Dunton, M.D.
Independent Director
Independent Director
--
--
Ms. Elizabeth (Liz) Massonhurlburt
Ms. Elizabeth (Liz) Massonhurlburt
Executive Vice President, Chief Clinical Strategy and Operations Officer
Executive Vice President, Chief Clinical Strategy and Operations Officer
--
--
Dr. Matthew T. (Matt) David, M.D.
Dr. Matthew T. (Matt) David, M.D.
Chief Financial Officer, Executive Vice President
Chief Financial Officer, Executive Vice President
--
--
Ms. Beth Zelnick Kaufman
Ms. Beth Zelnick Kaufman
Executive Vice President, Chief Legal and Compliance Officer, Corporate Secretary
Executive Vice President, Chief Legal and Compliance Officer, Corporate Secretary
--
--
Ver Mais
Nome
Nome/Posição
Posição
Ações detidas
Variação
Mr. Joseph Todisco
Mr. Joseph Todisco
Chief Executive Officer, Director
Chief Executive Officer, Director
323.43K
-2.01%
Mr. Steven W. Lefkowitz
Mr. Steven W. Lefkowitz
Independent Director
Independent Director
127.65K
-3.77%
Ms. Janet M. Dillione
Ms. Janet M. Dillione
Independent Director
Independent Director
53.47K
-31.86%
Ms. Erin Mistry
Ms. Erin Mistry
Executive Vice President, Chief Commercial Officer
Executive Vice President, Chief Commercial Officer
29.12K
-54.14%
Mr. Robert Stewart
Mr. Robert Stewart
Independent Director
Independent Director
11.00K
-69.44%
Mr. Dan Ferry
Mr. Dan Ferry
IR Contact Officer
IR Contact Officer
--
--
Detalhamento da receita
FY2025Q1
FY2024
Sem dados
Por RegiãoUSD
Nome
Receita
Proporção
United States
39.08M
0.00%
Por Empresa
Por Região
Sem dados
Distribuição de ações
Atualizado em: sáb, 16 de ago
Atualizado em: sáb, 16 de ago
Investidores
Tipos de investidores
Investidores
Investidores
Proporção
BlackRock Institutional Trust Company, N.A.
6.42%
Abdalkader (Shaibatalhamd Aymen)
6.22%
The Vanguard Group, Inc.
5.77%
Marshall Wace LLP
3.46%
Citadel Advisors LLC
2.30%
Outro
75.83%
Investidores
Investidores
Proporção
BlackRock Institutional Trust Company, N.A.
6.42%
Abdalkader (Shaibatalhamd Aymen)
6.22%
The Vanguard Group, Inc.
5.77%
Marshall Wace LLP
3.46%
Citadel Advisors LLC
2.30%
Outro
75.83%
Tipos de investidores
Investidores
Proporção
Investment Advisor
22.34%
Investment Advisor/Hedge Fund
13.04%
Hedge Fund
8.73%
Individual Investor
7.30%
Research Firm
1.48%
Sovereign Wealth Fund
1.26%
Pension Fund
0.63%
Bank and Trust
0.28%
Venture Capital
0.06%
Outro
44.87%
Participação acionária institucional
Atualizado em: ter, 1 de jul
Atualizado em: ter, 1 de jul
Período do relatório
N.º de instituições
Ações detidas
Proporção
Variação
2025Q2
280
26.40M
35.51%
-7.69M
2025Q1
281
29.73M
44.27%
-179.25K
2024Q4
252
24.74M
40.82%
-30.08K
2024Q3
228
19.79M
34.25%
-1.78M
2024Q2
217
17.74M
32.28%
-4.09M
2024Q1
218
17.92M
32.60%
-5.73M
2023Q4
217
19.38M
35.35%
-2.82M
2023Q3
208
18.46M
33.68%
-3.54M
2023Q2
197
19.74M
38.10%
+6.18M
2023Q1
190
11.28M
25.34%
-2.76M
Ver Mais
Atividade dos acionistas
Nome
Ações detidas
Proporção
Variação
Var. %
Data
BlackRock Institutional Trust Company, N.A.
4.31M
5.8%
+109.81K
+2.61%
Mar 31, 2025
The Vanguard Group, Inc.
3.63M
4.89%
+255.97K
+7.58%
Mar 31, 2025
Marshall Wace LLP
230.53K
0.31%
+230.53K
--
Mar 31, 2025
State Street Global Advisors (US)
1.54M
2.07%
+85.97K
+5.92%
Mar 31, 2025
Geode Capital Management, L.L.C.
1.43M
1.93%
+40.10K
+2.88%
Mar 31, 2025
Norges Bank Investment Management (NBIM)
940.59K
1.27%
+940.59K
--
Dec 31, 2024
Ver Mais
ETFs Relacionados
Atualizado em: qua, 6 de ago
Atualizado em: qua, 6 de ago
Nome
Proporção
Invesco Dorsey Wright Healthcare Momentum ETF
1.62%
SPDR S&P Pharmaceuticals ETF
1.31%
Direxion Daily Pharmaceutical & Medical Bl 3X ETF
0.81%
First Trust Active Factor Small Cap ETF
0.41%
Vanguard US Momentum Factor ETF
0.21%
iShares Micro-Cap ETF
0.18%
Goldman Sachs ActiveBeta US Small Cap Equity ETF
0.09%
ProShares Ultra Nasdaq Biotechnology
0.09%
iShares Biotechnology ETF
0.08%
Invesco Nasdaq Biotechnology ETF
0.08%
Ver Mais
Invesco Dorsey Wright Healthcare Momentum ETF
Proporção1.62%
SPDR S&P Pharmaceuticals ETF
Proporção1.31%
Direxion Daily Pharmaceutical & Medical Bl 3X ETF
Proporção0.81%
First Trust Active Factor Small Cap ETF
Proporção0.41%
Vanguard US Momentum Factor ETF
Proporção0.21%
iShares Micro-Cap ETF
Proporção0.18%
Goldman Sachs ActiveBeta US Small Cap Equity ETF
Proporção0.09%
ProShares Ultra Nasdaq Biotechnology
Proporção0.09%
iShares Biotechnology ETF
Proporção0.08%
Invesco Nasdaq Biotechnology ETF
Proporção0.08%
Dividendo
Um total de
0.00
USD foi distribuído em dividendos nos últimos 5 anos.
Data
Dividendo
Data de registro
Data de pagamento
Data ex-dividendo
Sem dados
Desdobramento de ações
Data
Tipo
Proporção
Sem dados
Data
Tipo
Proporção
Sem dados
